MGLL and neuropathy: Thus, peripheral inhibition of MAGL activity is sufficient to suppress aberrant behavioural sensitization in chemotherapy-induced neuropathy via a CB2 receptor mechanism without inducing unwanted CNS-mediated cannabimimetic effects, tolerance or physical dependence.